EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Neuroinflammatory Effects of a Macrocyclic Peptide-Peptoid Hybrid in Lipopolysaccharide-Stimulated BV2 Microglial Cells

Lu Sun, Soraya Wilke Saliba, Matthias Apweiler, Kamil Akmermer iD, Claudine Herlan, Christoph Grathwol iD, Antônio Carlos Pinheiro de Oliveira iD, Claus Normann, Nicole Jung, Stefan Bräse iD, Bernd L Fiebich iD

International Journal of Molecular Sciences · 18.04.2024 · 25 (8) · 4462

DOI: 10.3390/ijms25084462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.04.2024. Verfasst von Lu Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimmunology and Neurochemistry Research Group, Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medi…. Hauptthemen laut MEDLINE: Microglia, Lipopolysaccharides, Anti-Inflammatory Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baden-Wuerttemberg Ministry of Science, Research and Art, University of Freiburg Library, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation processes of the central nervous system (CNS) play a vital role in the pathogenesis of several neurological and psychiatric disorders like depression. These processes are characterized by the activation of glia cells, such as microglia. Clinical studies showed a decrease in symptoms associated with the mentioned diseases after the treatment with anti-inflammatory drugs. Therefore, the investigation of novel anti-inflammatory drugs could hold substantial potential in the treatment of disorders with a neuroinflammatory background. In this in vitro study, we report the anti-inflammatory effects of a novel hexacyclic peptide-peptoid hybrid in lipopolysaccharide (LPS)-stimulated BV2 microglial cells. The macrocyclic compound X15856 significantly suppressed Interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), c-c motif chemokine ligand 2 (CCL2), CCL3, C-X-C motif chemokine ligand 2 (CXCL2), and CXCL10 expression and release in LPS-treated BV2 microglial cells. The anti-inflammatory effects of the compound are partially explained by the modulation of the phosphorylation of p38 mitogen-activated protein kinases (MAPK), p42/44 MAPK (ERK 1/2), protein kinase C (PKC), and the nuclear factor (NF)-κB, respectively. Due to its remarkable anti-inflammatory properties, this compound emerges as an encouraging option for additional research and potential utilization in disorders influenced by inflammation, such as depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaLipopolysaccharidesAnti-Inflammatory AgentsAnimalsMiceCell LinePeptoidsInterleukin-6NF-kappa BChemokine CCL2PeptidesTumor Necrosis Factor-alphaChemokine CXCL2CytokinesNeuroinflammatory DiseasesChemokine CCL3Macrocyclic Compounds

Stichwörter der Autor:innen

chemokinescytokinesdepressionmicroglianeuroinflammationpeptoid

Substanzen

LipopolysaccharidesAnti-Inflammatory AgentsPeptoidsInterleukin-6NF-kappa BChemokine CCL2PeptidesTumor Necrosis Factor-alphaChemokine CXCL2Cytokines

Autor:innen und Institutionen

  • Neuroimmunology and Neurochemistry Research Group, Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, D-79104 Freiburg, Germany.
  • Institute of Organic Chemistry, Karlsruhe Institute of Technology (KIT), D-76131 Karlsruhe, Germany.
  • Institute of Biological and Chemical Systems-Functional Molecular Systems (IBCS-FMS), Karlsruhe Institute of Technology (KIT), Kaiserstrasse 12, D-76131 Karlsruhe, Germany.
  • Neuropharmacology Laboratory, Department of Pharmacology, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
  • Mechanisms of Depression Research Group, Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, D-79104 Freiburg, Germany.

ORCID-Profile: Kamil Akmermer, Christoph Grathwol, Antônio Carlos Pinheiro de Oliveira, Stefan Bräse, Bernd L Fiebich

Förderung

  • Baden-Wuerttemberg Ministry of Science, Research and Art
  • University of Freiburg Library
  • German Research Foundation
  • Repository Chemotion

Zitieren

APA

Sun, L., Wilke Saliba, S., Apweiler, M., Akmermer, K., Herlan, C., Grathwol, C., de Oliveira, A. C. P., Normann, C., Jung, N., Bräse, S., & Fiebich, B. L. (2024). Anti-Neuroinflammatory Effects of a Macrocyclic Peptide-Peptoid Hybrid in Lipopolysaccharide-Stimulated BV2 Microglial Cells. International Journal of Molecular Sciences, 25(8), 4462. https://doi.org/10.3390/ijms25084462

Vancouver

Sun L, Wilke Saliba S, Apweiler M, Akmermer K, Herlan C, Grathwol C, et al. Anti-Neuroinflammatory Effects of a Macrocyclic Peptide-Peptoid Hybrid in Lipopolysaccharide-Stimulated BV2 Microglial Cells. International Journal of Molecular Sciences. 2024;25(8):4462. doi:10.3390/ijms25084462

BibTeX
@article{Sun2024,
  author = {Sun, Lu and Wilke Saliba, Soraya and Apweiler, Matthias and Akmermer, Kamil and Herlan, Claudine and Grathwol, Christoph and de Oliveira, Antônio Carlos Pinheiro and Normann, Claus and Jung, Nicole and Bräse, Stefan and Fiebich, Bernd L},
  title = {Anti-Neuroinflammatory Effects of a Macrocyclic Peptide-Peptoid Hybrid in Lipopolysaccharide-Stimulated BV2 Microglial Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {8},
  pages = {4462},
  doi = {10.3390/ijms25084462}
}
Kostenlos starten →